Claudia Ireland

Dr

20082022

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

After a brief stint in the pharmaceutical industry, Claudia has returned to Monash to take up a Post Doctorate research position in the Intergrative Cardiovascular Pharmacology group, led by Prof. Robert Widdop. Continuing on from research completed for her PhD at Monash University, her main research focus is in the area of stroke and the role of the Renin Angiotensin System (RAS) in determining stroke outcome.

More recently, Claudia's research has taken on a more clinical focus as she explores whether the AT-2 receptor could be a potential target for stroke therapy and investigates the neuroprotective properties of various modulators of the RAS. Her current research utilizes an integrated perspective and encompasses both in vivo and in vitro techniques to elucidate the complex cascade that contributes to the neuronal damage resulting from stroke.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being